Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.435
-0.025 (-1.02%)
At close: Feb 13, 2026, 4:00 PM EST
2.440
+0.005 (0.21%)
After-hours: Feb 13, 2026, 6:05 PM EST
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $8.89 million as of February 13, 2026. Its market cap has decreased by -68.25% in one year.
Market Cap
8.89M
Enterprise Value
4.10M
1-Year Change
-68.25%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $8.89M, a decrease of -94.64%. That is a compound annual growth rate of -23.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.89M | 9.19% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 9.85M |
| GridAI Technologies | 9.78M |
| Bolt Biotherapeutics | 9.60M |
| CollPlant Biotechnologies | 9.51M |
| Chemomab Therapeutics | 9.11M |
| TransCode Therapeutics | 9.06M |
| Evogene | 8.75M |
| NuCana | 8.74M |